microRNA-30a-5p;
sex determining region Y-box 4;
progression;
melanoma;
MESENCHYMAL TRANSITION;
TUMOR-SUPPRESSOR;
POOR-PROGNOSIS;
GASTRIC-CANCER;
METASTASIS;
EXPRESSION;
PROGRESSION;
MICRORNAS;
GROWTH;
BIOGENESIS;
D O I:
10.3892/mmr.2018.9166
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
MicroRNA (miR)-30a-5p has been reported to suppress the progression of hepatocellular cancer, renal cell carcinoma, oral cancer and gastric cancer. However, whether miR-30a-5p is involved in the regulation of melanoma remains unclear. The present study revealed that miR-30a-5p was downregulated in melanoma tissues and cell lines. Overexpression of miR-30a-5p significantly inhibited the proliferation, migration and invasion of melanoma cells in vitro. In addition, ectopic expression of miR-30a-5p delayed tumor growth in vivo. In terms of mechanism, miR-30a-5p targeted sex determining region Y-box 4 (SOX4) and impeded the expression of SOX4 in melanoma cells. In addition, SOX4 was upregulated in melanoma tissues and cell lines when compared with normal tissues or cells. Furthermore, overexpression of SOX4 significantly rescued the proliferation, migration and invasion of melanoma cells transfected with miR-30a-5p mimics. Taken together, the results of the present study demonstrated that miR-30a-5p suppressed the proliferation, migration and invasion of melanoma cells in SOX4-dependent manner.
机构:
Jilin Univ, China Japan Union Hosp, Dept Urol Surg, Changchun 130000, Jilin, Peoples R ChinaJilin Univ, China Japan Union Hosp, Dept Urol Surg, Changchun 130000, Jilin, Peoples R China
Zong, Shi
Zhao, Jia
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Univ, China Japan Union Hosp, Dept Anesthesia, Changchun 130000, Jilin, Peoples R ChinaJilin Univ, China Japan Union Hosp, Dept Urol Surg, Changchun 130000, Jilin, Peoples R China
Zhao, Jia
Liu, Ling
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Univ, China Japan Union Hosp, Dept Pediat, Changchun 130000, Jilin, Peoples R ChinaJilin Univ, China Japan Union Hosp, Dept Urol Surg, Changchun 130000, Jilin, Peoples R China
Liu, Ling
[J].
ONCOTARGETS AND THERAPY,
2020,
13
: 7177
-
7188
机构:
Zhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R ChinaZhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R China
Chen, Chunhua
Tang, Junhua
论文数: 0引用数: 0
h-index: 0
机构:
First Peoples Hosp Fuyang, Dept Resp Med, Hangzhou 311400, Peoples R ChinaZhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R China
Tang, Junhua
Xu, Shan
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R ChinaZhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R China
Xu, Shan
Zhang, Wenxia
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R ChinaZhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R China
Zhang, Wenxia
Jiang, Hanliang
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R ChinaZhejiang Univ, Dept Pulm & Crit Care Med, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310016, Peoples R China